These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33011482)

  • 1. Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: The ENCHANTED trial.
    Xia C; Wang X; Lindley RI; Delcourt C; Zhou Z; Chen X; Carcel C; Malavera A; Calic Z; Anderson CS;
    Clin Neurol Neurosurg; 2020 Nov; 198():106254. PubMed ID: 33011482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined utility of white blood cell count and blood glucose for predicting in-hospital outcomes in acute ischemic stroke.
    You S; Ou Z; Zhang W; Zheng D; Zhong C; Dong X; Qiu C; Lu T; Cao Y; Liu CF
    J Neuroinflammation; 2019 Feb; 16(1):37. PubMed ID: 30764852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial.
    Minhas JS; Wang X; Lindley RI; Delcourt C; Song L; Woodward M; Lee TH; Broderick JP; Pontes-Neto OM; Kim JS; Ricci S; Lavados PM; Bath PM; Durham AC; Wang JG; Sharma VK; Demchuk AM; Martins SO; Chalmers J; Anderson CS; Robinson TG;
    J Hypertens; 2021 Feb; 39(2):280-285. PubMed ID: 33031175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
    Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
    J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early decompressive hemicraniectomy in thrombolyzed acute ischemic stroke patients from the international ENCHANTED trial.
    Xia C; Wang X; Lindley RI; Delcourt C; Chen X; Zhou Z; Guo R; Carcel C; Malavera A; Calic Z; Mair G; Wardlaw JM; Robinson TG; Anderson CS
    Sci Rep; 2021 Aug; 11(1):16495. PubMed ID: 34389772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target.
    Zhou Z; Xia C; Mair G; Delcourt C; Yoshimura S; Liu X; Chen Z; Malavera A; Carcel C; Chen X; Wang X; Al-Shahi Salman R; Robinson TG; Lindley RI; Chalmers J; Wardlaw JM; Parsons MW; Demchuk AM; Anderson CS
    Int J Stroke; 2022 Jun; 17(5):566-575. PubMed ID: 34096413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study.
    Wang X; Minhas JS; Moullaali TJ; Di Tanna GL; Lindley RI; Chen X; Arima H; Chen G; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Thang NH; Wang JG; Woodward M; Chalmers J; Song L; Anderson CS; Robinson TG;
    Stroke; 2022 Mar; 53(3):779-787. PubMed ID: 34702064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study.
    Sun L; Song L; Yang J; Lindley RI; Robinson T; Lavados PM; Delcourt C; Arima H; Ovbiagele B; Chalmers J; Anderson CS; Wang X
    Stroke Vasc Neurol; 2021 Sep; 6(3):395-401. PubMed ID: 33526633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
    Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
    Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.
    Zhou Z; Delcourt C; Xia C; Yoshimura S; Carcel C; Torii-Yoshimura T; You S; Malavera A; Chen X; Hackett ML; Woodward M; Chalmers J; Xu J; Robinson TG; Parsons MW; Demchuk AM; Lindley RI; Mair G; Wardlaw JM; Anderson CS
    Neurology; 2021 Mar; 96(11):e1512-e1526. PubMed ID: 33536271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
    Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
    Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).
    Ahmed N; Dávalos A; Eriksson N; Ford GA; Glahn J; Hennerici M; Mikulik R; Kaste M; Lees KR; Lindsberg PJ; Toni D;
    Arch Neurol; 2010 Sep; 67(9):1123-30. PubMed ID: 20837858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
    N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study.
    Saxena A; Anderson CS; Wang X; Sato S; Arima H; Chan E; Muñoz-Venturelli P; Delcourt C; Robinson T; Stapf C; Lavados PM; Wang J; Neal B; Chalmers J; Heeley E;
    Stroke; 2016 Mar; 47(3):682-8. PubMed ID: 26814235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke.
    Osei E; den Hertog HM; Berkhemer OA; Fransen PSS; Roos YBWEM; Beumer D; van Oostenbrugge RJ; Schonewille WJ; Boiten J; Zandbergen AAM; Koudstaal PJ; Dippel DWJ;
    Stroke; 2017 May; 48(5):1299-1305. PubMed ID: 28389610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.